RedHill Biopharma (RDHL) Posts Q3 Loss of 7c/Share

RedHill Biopharma (NASDAQ: RDHL) reported Q3 EPS of ($0.07), $0.51 better than the analyst estimate of ($0.58).

For earnings history and earnings-related data on RedHill Biopharma (RDHL) click here.

You May Also Be Interested In

• Meritage Homes Corporation (MTH) Tops Q1 EPS by 151c; offers guidance
• ATN International (ATNI) Misses Q1 EPS by 46c ; Offers Guidance
• First Bancorp. (FBNC) Misses Q1 EPS by 2c